Fast Market Research

Report Published: "Inborn Gene or Chromosome Alterations - Pipeline Review, 2015"

Fast Market Research announces the availability of the new GlobalData report, "Inborn Gene or Chromosome Alterations - Pipeline Review, 2015", on their comprehensive research portal


Boston, MA -- (SBWIRE) -- 10/30/2015 -- GlobalData's Medical Devices sector report, "Inborn Gene or Chromosome Alterations - Pipeline Review, 2015" provides an overview of genetic tests for Inborn Gene or Chromosome Alterations currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key genetic tests for Inborn Gene or Chromosome Alterations pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Get More Details on this Report and a Full Table of Contents at Inborn Gene or Chromosome Alterations - Pipeline Review, 2015

Report Scope

-Extensive coverage of the genetic tests for Inborn Gene or Chromosome Alterations under development

-The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

-The report reviews the major players involved in the development of genetic tests for Inborn Gene or Chromosome Alterations and list all their pipeline projects

-The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

-The report provides key clinical trial data of ongoing trials specific to pipeline products

-Recent developments in the segment / industry

Reasons to Get this Report

The report enables you to -

-Formulate significant competitor information, analysis, and insights to improve R&D strategies

-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

-Identify and understand important and diverse types of genetic tests for Inborn Gene or Chromosome Alterations under development

-Develop market-entry and market expansion strategies

-Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

-In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: AC-Gen Reading Life S.L., Admera Health, LLC, Agena Bioscience, Inc, Ariosa Diagnostics, Inc., Atomic International, Baylor College of Medicine, BCML GmbH, CardioDx, Inc., Celera Corporation, Celula, Inc., Children's Hospital Boston, China Medical Technologies, Inc., Da An Gene Co., Ltd., Dana-Farber Cancer Institute, Inc., Epinex Diagnostics Incorporated, Genentech, Inc., German Cancer Research Center, GILUPI Nanomedizin, Hadassah Medical Center, Helicos BioSciences Corporation, Illumina, Inc., IntegraGen SA, Interleukin Genetics, Inc., JS Genetics Inc., Laboratory Corporation of America Holdings, Laval University, LifeCodexx AG, Maastricht University Medical Center, Massachusetts Eye and Ear Infirmary, Medical Research Council, Micromedic Technologies Ltd, Multiplicom N.V., Myriad Genetics, Inc., Natera, Inc., National University of Singapore, NewGene Ltd, NX PharmaGen Inc., Paragon Medical, Inc., Population Diagnostics Inc., Qiagen N.V., Quantamerix, Sapien Biosciences, Seegene, Inc., Sequenom, Inc., Stanford University, The Johns Hopkins University, The Sheba Medical Center, The University of Utah, TrovaGene, Inc., University of Colorado, University of Washington, VitaPath Genetics, Inc., Xiamen Zeesan Biotech Co.,Ltd, Yale University

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

-Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
-Errant Gene Therapeutics, LLC - Product Pipeline Review - 2015
-Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015
-American Gene Technologies International Inc. - Product Pipeline Review - 2015
-Hepatitis C - Pipeline Review, H1 2015